GlassScriptPhysician profile
Alex Dinkchian
NPI 1104449321
$6,051.48
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,487 · 2021: $42.39 · 2022: $231 · 2023: $2,728 · 2024: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,637 · Travel and Lodging: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,636.52 |
| Travel and Lodging | $654.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micromed INC | $2,486.74 | 2020 | |
| Stryker Corporation | $2,441.99 | 2022-2024 | Prostep, Augment Injectable, Valor |
| Biotissue Holdings INC. | $651.95 | 2023-2024 | |
| Mimedx Group, INC. | $203.47 | 2024 | |
| Angiodynamics, INC. | $123.18 | 2024 | Auryon Laser System 100-120 Vac |
| Kci USA, INC. | $43.20 | 2022-2023 | V.A.C. Veraflo Cleanse Choice, V.A.C. Dermatac, V.A.C. Veraflo |
| Ucb, INC. | $42.39 | 2021 | |
| Treace Medical Concepts, INC. | $39.52 | 2023 | |
| Depuy Synthes Sales INC. | $19.04 | 2023 | Na, N/A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Dinkchian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.